Salah A. Aziz-Abdel

Assiut Branch
Asyut, AST 71524, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseases.

Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseases.

Journal: Bioorganic & medicinal chemistry letters

Published: July 17, 2025

Anti-Parkinson's activity of Phragmites communis Trin. rhizomes and their liposomal formulation: Insights from chemical and molecular docking analyses.

Anti-Parkinson's activity of Phragmites communis Trin. rhizomes and their liposomal formulation: Insights from chemical and molecular docking analyses.

Journal: Fitoterapia

Published: January 10, 2025

In Vitro and Randomized Controlled Clinical Study of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported with In Silico Studies and Network Analysis.

In Vitro and Randomized Controlled Clinical Study of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported with In Silico Studies and Network Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 24, 2024

Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation.

Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation.

Journal: Bioorganic & medicinal chemistry letters

Published: January 21, 2024

A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents.

A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents.

Journal: Archiv der Pharmazie

Published: December 24, 2023

Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.

Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: August 25, 2023

New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition.

New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition.

Journal: Archiv der Pharmazie

Published: January 17, 2022

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.

Journal: European journal of medicinal chemistry

Published: June 22, 2021

Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile.

Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile.

Journal: Bioorganic chemistry

Published: January 30, 2021

Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.

Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.

Journal: Bioorganic chemistry

Published: January 26, 2021

JNK signaling as a target for anticancer therapy.

JNK signaling as a target for anticancer therapy.

Journal: Pharmacological reports : PR

Published: January 06, 2021

Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives.

Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives.

Journal: Pharmacological reports : PR

Published: August 08, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026